The report offers detailed coverage of Rabies Vaccine industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Rabies Vaccine by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Rabies vaccine is an active immunizing agent used to prevent infection caused by the rabies virus. The vaccine works by causing your body to produce its own protection (antibodies) against the rabies virus.
Every year more than 5.5 million people have died for rabies, mostly in Asia and Africa. With the implementation of China's two-child policy, downstream demand for rabies vaccine will not decrease in the coming few years.
Rabies vaccine is an irreplaceable product, so profile of rabies vaccine is very large. But due to its security requirements than the general drugs, the entire vaccine industry from R & D, production to distribution, sales and after-sales feedback link subject to very strict regulation. So, production companies are not as much as we imagined.
The most wildly used rabies vaccine is Vero cell rabies vaccine (VRV), which takes about 80.85% in 2016.
Nowadays, global rabies vaccine production is mainly concentrated in China, Europe and North America. In 2016, China rabies vaccine production takes about 74.34% and Europe production takes about 7.46%.
The report forecast global Rabies Vaccine market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.
First, this report covers the present status and the future prospects of the global Rabies Vaccine market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
GSK (Novartis)
Sanofi-Pasteur
Chengda
Yisheng
Prcmise
VACN
Changsheng
BCHT
Hissen
At the same time, we classify Rabies Vaccine according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market Segment as follows:
Market by Order Type
Vero Cell Rabies Vaccine
BHK
Chick Embryo Cell Rabies Vaccine
Other
Market by Application
Pre-exposure Prophylaxis
Post-exposure Prophylaxis
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Rabies Vaccine market for the forecast period 2021 - 2025?
• What are the driving forces in the Rabies Vaccine market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Rabies Vaccine industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?